• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

SCOPA 2022: A review of topical medication classes in eyecare

Video

Brad Sutton, OD, FAAO, FORS, shares highlights from his SCOPA 2022 presentation, "Topical Pharmacology Rounds."

Brad Sutton, OD, FAAO, FORS, clinical professor at Indiana University School of Optometry, and service chief of the Indianapolis Eye Care Center speaks with Optometry Times® editor Kassi Jackson, sharing highlights from his presentation, "Topical pharmacology rounds," which he presented during this year's South Carolina Optometric Physicians Association's (SCOPA) annual meeting in hilton Head.

This transcript has been lightly edited for clarity:

Brad Sutton, OD, FAAO, FORS:

This is a talk I've given ... throughout the country, and it seems to be a pretty well-received review of basically all topical medication classes that we use in optometry—or eyecare.— in general.

I kind of cover each drug that we have out there, kind of hit on some newer drugs that are just coming to the market, some things in the pipeline a little bit.

And the goal is to give a little bit of background on how the drugs work, and how one drug may be similar or different from another, but my real goal during the talk is always to say, "Okay, here are some clinical nuances between drug X and drug Y," and help attendees better use those medications in their practice to take care of their patients.

We cover antibiotics, anti-inflammatories, nonsteroidal anti-inflammatories, allergy medicines, glaucoma drops, antivirals, and basically every category you can think of.

Related Videos
Charles Leclercq, CEO of ARxVision, details the new ARx AI headset and its uses
Jessica Steen, OD, FAAO, discusses systemic medication and ocular adverse effects at Vision Expo East 2024
The Vision Council CEO Ashley Mills gives a preview of the 2024 Vision Expo East event
Marc R Bloomenstein, OD, FAAO, chats with Optometry Times about the benefits of Vevye in the treatment of dry eye
© 2024 MJH Life Sciences

All rights reserved.